The Positive Result Problem: Prescribed Cannabis and the UK Workplace Drug Test

There's a particular kind of silence that follows a positive drug test result. It's not the dramatic kind you see on telly. It's the HR email that arrives with the phrase "we'd like a quick chat" and a calendar invite attached.

For a growing number of UK workers, that chat is now about legally prescribed cannabis. Not a weekend spliff, not a dodgy vape from a mate — a Schedule 2 controlled medicine, dispensed by a pharmacy, signed off by a specialist prescriber, taken exactly as directed.

And yet the test doesn't know any of that. It just knows there's a metabolite in the sample.

What the test actually detects

Most UK workplace screening uses urine immunoassay, sometimes backed up with a lab confirmation. What those tests look for is not cannabis itself but carboxy-THC, an inactive metabolite that hangs around in the body for days, weeks, sometimes considerably longer depending on body composition, frequency of use and a dozen other variables nobody fully controls.

That's the first thing to get straight: a positive result is evidence of exposure, not impairment. It cannot tell your employer whether you were affected at 9am on Tuesday, or whether you took your prescribed oil at 10pm on Sunday before bed. The test is a blunt instrument being asked to answer a forensic question, and it can't.

Where policy ends and law begins

A lot of UK employers still run on a template drug and alcohol policy written in a different era, when the only people testing positive for cannabis were, in the policy's imagination, either recreational users or people with a problem. Many of those documents haven't been meaningfully updated since medical cannabis prescribing became legal in 2018.

Here's the legal scaffolding. Under the Equality Act 2010, a person with a long-term condition that has a substantial adverse effect on day-to-day activity may be disabled for the purposes of the Act — and many patients using prescribed cannabis for chronic pain, MS spasticity, severe anxiety, ADHD or treatment-resistant conditions will meet that threshold. Employers then have a duty to make reasonable adjustments and not to subject that person to discrimination arising from their disability.

That doesn't mean an employer must accept a prescribed medicine unconditionally. It means they have to properly consider the situation rather than reflexively binning the applicant or employee. A blanket "zero tolerance" policy, applied without exception to a disabled employee's lawful medicine, is exactly the sort of thing tribunals tend to look at sideways. High-profile claims — notably the long-running Collin v Chief Constable of Staffordshire Police litigation — have pushed the issue into public view and made boardrooms a little more nervous than they used to be.

Safety-critical is a real defence — but not a magic word

Let's be fair to employers. Some jobs genuinely carry elevated risk: HGV driving, rail operations, offshore work, aviation, heavy plant, certain healthcare and care roles. Sector regulators and duty-of-care obligations under health and safety law mean an employer can't simply wave a prescription through and hope for the best.

The test for them is objectivity. Is the restriction justified by genuine, evidence-based risk? Have they considered alternatives — adjusted duties, a different shift pattern, temporary redeployment, closer supervision? Or have they reached for the word "safety-critical" because it ends the conversation quickly?

Being able to recite a policy isn't the same as having applied your mind to it. That distinction is where most disputes live.

The pre-employment trap

Job hunting as a prescribed patient is its own small nightmare. Do you declare at application? At interview? After the offer?

There's no universally correct answer, but there is a pattern worth knowing. Many employers only test after a conditional offer, and many only ask about medication at that stage via a health questionnaire or occupational health referral. Declaring on that form, in writing, with your prescription details attached, tends to produce a far better outcome than being discovered by a lab result three weeks later. Timing matters less than transparency.

If you're applying for a role where a positive test is near-certain, it's usually smarter to raise it with occupational health — not your prospective line manager — as early as the process allows. Occupational health teams are clinically trained, bound by confidentiality, and used to talking about medication. A hiring manager is not, and the conversation can go sideways fast.

A practical playbook for the positive result

If the result is already in and the meeting is already booked, here's the shape of a sensible response.

Ask for the policy in writing. All of it. The testing procedure, the cut-off levels, the confirmation process, the disciplinary consequences. You're entitled to know the rules you're being judged against.

Get documentation from your prescriber. A letter confirming your condition, your prescription, your dosage, your titration schedule, and — critically — a clinical opinion on whether your medicine impairs your ability to do your specific job. Ask them to address fitness for duty directly.

Put everything in writing. Requests for reasonable adjustments, offers to attend occupational health, explanations of your prescription. Email is your friend. Tribunals read contemporaneous documents, not recollections.

Request an occupational health referral. An OH assessment reframes the issue from "misconduct" to "health and capability", which is usually the right framing.

Don't offer to stop your medicine as a bargaining chip. It's tempting to say you'll come off it to save the job. It also undermines the legal position you're standing on, and your health is not a negotiating asset.

Know your clock. If a dispute does escalate, ACAS early conciliation and employment tribunal deadlines run on tight timetables — generally three months less one day from the act you're complaining about. Get advice early rather than after the deadline has quietly passed.

The culture bit nobody writes into policy

There's a gap between what the law allows and what a workplace culture tolerates. Plenty of UK patients work somewhere they'd rather not mention their prescription at all, because the reaction they expect isn't discrimination — it's the low-grade weirdness that follows. The raised eyebrow. The sudden exclusion from client-facing work. The informal word that you might want to "take some time".

That stuff is harder to litigate, and it's real. It's also why disclosure decisions remain genuinely difficult, and why so many people with a perfectly lawful prescription still treat it like a secret.

The direction of travel is clear enough. Prescribing volumes are up, tribunal awareness is up, and employers are slowly learning that a positive result is a question rather than an answer. But policy is one thing and practice is another, and in 2026 the gap between the two is still where careers get bruised.

If you're heading into that HR meeting any time soon: bring the paperwork, stay calm, and remember you're not asking for a favour. You're asking for the law to be applied properly.